
Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease

White paper: Advancing drug discovery for neurodegenerative diseases

Research highlights: iPSCs for gene therapy development

Case Study: A model of Alzheimer’s disease

Research highlights: Drug repurposing for Parkinson's disease, using iPSCs

Research highlights: Human iPSC technology can help reduce the gap between preclinical and clinical studies